476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19
Main Authors: | Na Chen, Tingting Zhong, Zhaoliang Huang, Xinghua Pang, Konyew Kwek, Chris Wynne, Adam Konpa, Maxwell Zhongmin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid tumors or lymphomas
by: Yu Xia, et al.
Published: (2020-11-01) -
Plant-Produced Monoclonal Antibody as Immunotherapy for Cancer
by: Meher Un Nessa, et al.
Published: (2020-01-01) -
Antibody therapy: Substitution-immunomodulation -monoclonal immunotherapy
by: Narinder K Mehra
Published: (2019-01-01) -
Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy
by: Ghislain Moussavou, et al.
Published: (2015-01-01) -
Fe de erratas (Vol. 47.6)
by: Equipo Editorial
Published: (2012-02-01)